“Rising Awareness of PBH Among patients and physicians”
- One prominent trend in the PBH treatment market is the increasing awareness of this underdiagnosed condition
- The rise in post-bariatric surgical procedures globally has heightened focus on the long-term management of metabolic complications such as PBH
- For instance, healthcare systems are adopting proactive screening and multidisciplinary treatment approaches, incorporating medications such as acarbose and diazoxide to reduce the frequency and severity of hypoglycemic episodes
- This trend is significantly transforming postoperative care in bariatric surgery, emphasizing patient education, diet management, and pharmacological intervention
- The post-bariatric hypoglycemia treatment market is poised for steady growth, supported by advancements in treatment strategies, growing clinical trials for new drug candidates, and the increasing need for patient-centric care as obesity rates continue to rise globally, effective management of PBH will remain a critical aspect of post-surgical outcomes and long-term patient health
